Related Experiment Video
Updated: May 24, 2026

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
[Complement--a phylogenetically old system as a new player in the development of atherosclerosis]
1Universitätsklinik für Hämatologie, Hämostase Forschungslabor, Universitätsspital und Universität Bern, Schweiz.
Insights
The complement system, part of innate immunity, drives inflammation in atherosclerosis and thrombosis. Targeting it may offer new treatments for cardiovascular diseases and ischemic events.
Area of Science:
- Immunology
- Cardiovascular Science
Context:
- Atherosclerotic diseases, including coronary artery disease and ischemic stroke, stem from chronic arterial wall inflammation.
- The complement system, a key innate immune component, significantly influences atherosclerotic plaque development and thrombotic events.
Purpose:
- To explore the dual role of the complement system in atherosclerosis: promoting inflammation and thrombosis, while also offering atheroprotective clearance of apoptotic material.
- To highlight the intricate interplay between complement activation and coagulation pathways in linking inflammation to thrombosis.
Summary:
- The complement system's pro-inflammatory actions contribute to atherosclerotic plaque progression and acute thrombotic events.
- Evidence suggests a critical link between complement and coagulation systems, exacerbating inflammation and thrombosis.
- Conversely, the complement system aids in clearing apoptotic debris, potentially exerting an atheroprotective effect.
Impact:
- Understanding these complex complement-mediated mechanisms is crucial for developing novel therapeutic and diagnostic strategies for cardiovascular diseases.
- Targeting the complement system presents a promising avenue for reducing tissue damage in acute ischemic events.
- The potential for early anti-inflammatory and anti-complement therapies to prevent atherosclerosis warrants further intensive research.
Abstract:
Atherosclerotic diseases such as coronary artery disease and ischaemic stroke are caused by chronic inflammation in arterial vessel walls. The complement system is part of the innate immune system. It is involved in many processes contributing to onset and development of atherosclerotic plaques up to the final stage of acute thrombotic events. This is due to its prominent role in inflammatory processes. In addition, there is increasing evidence that interactions between complement and coagulation provide a link between inflammation and thrombosis. On the other hand, the complement system also has an atheroprotective function through the clearance of apoptotic material. The knowledge of these complex mechanisms will become increasingly important, also for clinicians, since it may lead to novel therapeutic and diagnostic options. Therapies targeting the complement system have the potential to reduce tissue damage caused by acute ischaemic events. Whether early anti-inflammatory and anti-complement therapy may be able to prevent atherosclerosis, remains a hot topic for research.
Related Concept Videos
Atherosclerosis I: Introduction
Complement System
Atherosclerosis III: Management
Coronary Artery Disease II: Pathophysiology
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Inflammation

